Tootsie Roll (TR) | Financial Analysis & Statements
Tootsie Roll Industries, Inc. Mid-cap Consumer Defensive
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
196.3M
Gross Profit
70.1M
35.72%
Operating Income
33.4M
17.01%
Net Income
28.8M
14.65%
Balance Sheet Metrics
Total Assets
1.3B
Total Liabilities
313.4M
Shareholders Equity
940.6M
Debt to Equity
0.33
Cash Flow Metrics
Operating Cash Flow
79.2M
Free Cash Flow
61.0M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Tootsie Roll Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 732.5M | 723.2M | 769.4M | 687.0M | 570.8M |
| Cost of Goods Sold | 474.1M | 470.0M | 512.5M | 454.2M | 371.5M |
| Gross Profit | 258.4M | 253.2M | 256.8M | 232.7M | 199.2M |
| Gross Margin % | 35.3% | 35.0% | 33.4% | 33.9% | 34.9% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 157.5M | 152.7M | 155.0M | 122.0M | 132.1M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 157.5M | 152.7M | 155.0M | 122.0M | 132.1M |
| Operating Income | 100.9M | 100.5M | 101.8M | 110.8M | 67.1M |
| Operating Margin % | 13.8% | 13.9% | 13.2% | 16.1% | 11.8% |
| Non-Operating Items | |||||
| Interest Income | 20.2M | 9.6M | 5.2M | 2.6M | 2.7M |
| Interest Expense | 447.0K | 509.0K | 337.0K | 104.0K | 46.0K |
| Other Non-Operating Income | 16.6M | 17.3M | 13.2M | -15.2M | 15.9M |
| Pre-tax Income | 137.2M | 126.9M | 119.9M | 98.1M | 85.7M |
| Income Tax | 37.3M | 40.1M | 28.0M | 22.2M | 20.4M |
| Effective Tax Rate % | 27.1% | 31.6% | 23.4% | 22.7% | 23.8% |
| Net Income | 100.0M | 86.8M | 91.9M | 75.9M | 65.3M |
| Net Margin % | 13.6% | 12.0% | 11.9% | 11.0% | 11.4% |
| Key Metrics | |||||
| EBITDA | 142.1M | 128.7M | 125.8M | 131.9M | 88.5M |
| EPS (Basic) | - | $1.18 | $1.28 | $1.04 | $0.89 |
| EPS (Diluted) | - | $1.18 | $1.28 | $1.04 | $0.89 |
| Basic Shares Outstanding | - | 73459600 | 71921810 | 73020686 | 73683674 |
| Diluted Shares Outstanding | - | 73459600 | 71921810 | 73020686 | 73683674 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Tootsie Roll Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 127.2M | 138.8M | 75.9M | 53.3M | 105.8M |
| Short-term Investments | 49.5M | 55.8M | 95.5M | 96.1M | 40.0M |
| Accounts Receivable | 47.9M | 43.8M | 55.6M | 58.6M | 54.9M |
| Inventory | 75.2M | 77.6M | 94.9M | 84.3M | 55.5M |
| Other Current Assets | - | - | - | - | - |
| Total Current Assets | 321.5M | 333.6M | 340.7M | 309.0M | 268.3M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 5.0M | 6.0M | 7.1M | 4.7M | 7.4M |
| Goodwill | 321.5M | 321.5M | 321.5M | 321.5M | 321.5M |
| Intangible Assets | 175.0M | 175.0M | 175.0M | 175.0M | 175.0M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 9.4M | 13.2M | 16.9M | 1.9M | 2.0M |
| Total Non-Current Assets | 932.5M | 813.6M | 743.7M | 709.8M | 750.3M |
| Total Assets | 1.3B | 1.1B | 1.1B | 1.0B | 1.0B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 15.9M | 13.4M | 15.8M | 25.2M | 15.0M |
| Short-term Debt | 2.1M | 2.3M | 2.4M | 1.8M | 2.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 98.5M | 87.3M | 94.9M | 90.1M | 80.0M |
| Non-Current Liabilities | |||||
| Long-term Debt | 11.8M | 12.5M | 13.5M | 11.5M | 13.8M |
| Deferred Tax Liabilities | 66.6M | 54.5M | 45.5M | 45.0M | 45.5M |
| Other Non-Current Liabilities | 127.7M | 113.8M | 97.7M | 80.0M | 97.9M |
| Total Non-Current Liabilities | 215.0M | 189.5M | 166.4M | 145.8M | 169.9M |
| Total Liabilities | 313.4M | 276.8M | 261.3M | 235.9M | 249.8M |
| Equity | |||||
| Common Stock | 50.7M | 49.4M | 48.2M | 47.4M | 46.6M |
| Retained Earnings | 65.5M | 57.9M | 62.9M | 48.3M | 39.5M |
| Treasury Stock | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 940.6M | 870.4M | 823.1M | 782.9M | 768.8M |
| Key Metrics | |||||
| Total Debt | 13.9M | 14.8M | 15.9M | 13.3M | 15.9M |
| Working Capital | 223.0M | 246.3M | 245.8M | 218.9M | 188.3M |
Balance Sheet Composition
Tootsie Roll Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 100.0M | 86.8M | 91.9M | 75.9M | 65.3M |
| Depreciation & Amortization | 19.1M | 18.2M | 18.2M | 17.7M | 17.6M |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -600.0K | 29.4M | -12.3M | -24.1M | -1.5M |
| Operating Cash Flow | 130.1M | 142.2M | 96.9M | 71.0M | 80.1M |
| Investing Activities | |||||
| Capital Expenditures | - | - | - | - | - |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | -135.9M | -111.0M | -94.3M | -97.7M | -111.2M |
| Investment Sales | 59.7M | 93.1M | 106.9M | 52.4M | 48.3M |
| Investing Cash Flow | -76.3M | -17.8M | 12.6M | -45.2M | -60.5M |
| Financing Activities | |||||
| Share Repurchases | -6.5M | -13.5M | -33.1M | -31.9M | -30.2M |
| Dividends Paid | -26.1M | -25.5M | -25.1M | -24.6M | -24.1M |
| Debt Issuance | - | - | - | 4.0M | 3.8M |
| Debt Repayment | -3.1M | -3.9M | -3.5M | -3.8M | -3.6M |
| Financing Cash Flow | -35.6M | -43.1M | -61.7M | -56.3M | -54.0M |
| Free Cash Flow | 96.4M | 120.9M | 67.8M | 48.7M | 53.9M |
| Net Change in Cash | 18.2M | 81.2M | 47.9M | -30.5M | -34.3M |
Cash Flow Trend
Tootsie Roll Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
32.04
Forward P/E
-21.85
Price to Book
3.40
Price to Sales
4.37
PEG Ratio
-21.85
Profitability Ratios
Profit Margin
13.66%
Operating Margin
17.98%
Return on Equity
11.04%
Return on Assets
6.11%
Financial Health
Current Ratio
3.26
Debt to Equity
1.48
Beta
0.48
Per Share Data
EPS (TTM)
$1.33
Book Value per Share
$12.54
Revenue per Share
$9.76
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| TR | 3.1B | 32.04 | 3.40 | 11.04% | 13.66% | 1.48 |
| Mondelez | 74.1B | 29.70 | 2.78 | 9.33% | 6.36% | 84.85 |
| Hershey | 38.9B | 43.48 | 8.26 | 18.89% | 7.55% | 123.76 |
| Sow Good | 33.1M | 4.61 | - | -46.38% | 0.00% | -0.61 |
| Rocky Mountain | 20.3M | -2.53 | 2.82 | -50.96% | -13.62% | 153.55 |
Financial data is updated regularly. All figures are in the company's reporting currency.






